Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT2 | P31751 | 1/20 | 0.56 |
| ▸ | HRH1 | P35367 | 7/20 | 0.44 |
| ▸ | MAOA | P21397 | 1/20 | 0.43 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.41 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11588923 | 0.94 | — | — | |
| Hydrochloric Acid SCHEMBL16862912 | 0.92 | AKT2 (0.61) | AKT2HRH1HRH3HRH4 | |
| Hydrochloric Acid SCHEMBL31274777 | 0.92 | AKT2 (0.61) | AKT2HRH1HRH3HRH4 | |
| Hydrochloric Acid SCHEMBL11590343 | 0.92 | AKT2 (0.61) | AKT2HRH1HRH3HRH4 | |
| SCHEMBL24866428 | 0.87 | AKT2 (0.44) | AKT2 | |
| SCHEMBL1751652 | 0.85 | — | — | |
| Hydrochloric Acid SCHEMBL1549960 | 0.83 | AKT2 (0.46) | AKT2HRH3HRH4 | |
| Hydrochloric Acid SCHEMBL19437534 | 0.83 | — | — | |
| SCHEMBL21263656 | 0.79 | NOS2 (0.44) | AKT2 | |
| SCHEMBL458851 | 0.79 | TDP1 (0.44) | AKT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025081019-A1 | KIF MODULATOR COMPOUNDS AND METHODS OF USE | IAMBIC THERAPEUTICS, INC. (US) | 2025-04-17 | — | — | WO | disclosed |
| US-20080305041-A1 | Pf4 Pharmacophores and Their Uses | BIOQUANTA CORP. (US) | 2008-12-11 | — | — | US | disclosed |
| EP-1834267-A2 | PF4 PHARMACOPHORES AND THEIR USES | Bioquanta Corp. (US) | 2007-09-19 | — | — | EP | disclosed |
| WO-2006055959-A2 | PF4 PHARMACOPHORES AND THEIR USES | BIOQUANTA CORP. (US) | 2006-05-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080305041-A1 | Pf4 Pharmacophores and Their Uses | PF4, PXMP4, PFN1 | AKT2 4528/4885HRH1 1740/4885MAOA 3952/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.